Francesco Lanza, Benessere Condiviso, Bologna, Baskerville, 2022, pp. 34 . [libro]
Kulasekararaj, A; Lanza, F; Arvanitakis, A; Langemeijer, SMC; Chonat, S; Chow, V; Pan, J; Saportas, Y; Hanes, V; Henary, H, Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria, «BLOOD», 2022, 140, pp. 8660 - 8662 [abstract]
Buccisano, Francesco; Palmieri, Raffaele; Piciocchi, Alfonso; Arena, Valentina; Candoni, Anna; Melillo, Lorella; Calafiore, Valeria; Cairoli, Roberto; de Fabritiis, Paolo; Storti, Gabriella; Salutari, Prassede; Lanza, Francesco; Martinelli, Giovanni; Luppi, Mario; Capria, Saveria; Maurillo, Luca; Del Principe, Maria Ilaria; Paterno, Giovangiacinto; Irno Consalvo, Maria Antonietta; Ottone, Tiziana; Lavorgna, Serena; Voso, Maria Teresa; Fazi, Paola; Vignetti, Marco; Arcese, William; Venditti, Adriano, ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol, «BLOOD ADVANCES», 2022, 6, pp. 2510 - 2516 [articolo]Open Access
Marconi, G; Piciocchi, A; Audisio, E; Priolo, G; Papayannidis, C; Martelli, M; Paoloni, F; Lemoli, RM; Bocchia, M; Lanza, F; Lico, A; Ciceri, F; Della Porta, MG; Frigeni, M; Giaccone, L; Beltrami, G; Borlenghi, E; Di Chio, MC; Selleri, C; Crea, E; Urbino, I; Sartor, C; Minotti, C; Guolo, F; La Sala, E; Nanni, J; Simonetti, G; Bochicchio, MT; Saglio, G; Venditti, A; Vignetti, M; Fazi, P; Martinelli, G, Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia, «BLOOD», 2022, 140, pp. 1705 - 1707 [abstract]
Greinix, Hildegard T; Eikema, Dirk-Jan; Koster, Linda; Penack, Olaf; Yakoub-Agha, Ibrahim; Montoto, Silvia; Chabannon, Christian; Styczynski, Jan; Nagler, Arnon; Robin, Marie; Robinson, Stephen; Chalandon, Yves; Mikulska, Malgorzata; Schönland, Stefan; Peric, Zinaida; Ruggeri, Annalisa; Lanza, Francesco; De Wreede, Liesbeth C; Mohty, Mohamad; Basak, Grzegorz W; Kröger, Nicolaus, Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study, «HAEMATOLOGICA», 2022, 107, pp. 1054 - 1063 [articolo]Open Access
Francesco Lanza; Michela Rondoni, Issue Highlights-July 2022, «CYTOMETRY. PART B, CLINICAL CYTOMETRY», 2022, 102, pp. 267 - 271 [articolo]
Lanza, Francesco; Monaco, Federica; Ciceri, Fabio; Cairoli, Roberto; Sacchi, Maria Vittoria; Guidetti, Anna; Marchetti, Monia; Massaia, Massimo; Arcaini, Luca; Krampera, Mauro; Mohamed, Sara; Gherlinzoni, Filippo; Mecucci, Cristina; Gentile, Massimo; Romano, Ilaria; Venditti, Adriano; Ruggeri, Marco; Ferrero, Dario; Coviello, Elisa; Fabbri, Elisabetta; Corradini, Paolo; Passamonti, Francesco, Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 857 - 863 [articolo]
Maffini, Enrico; Labopin, Myriam; Beelen, Dietrich Wilhelm; Kroeger, Nicolaus; Arat, Mutlu; Wilson, Keith M O; Bay, Jacques-Olivier; Ganser, Arnold; Martin, Hans; Passweg, Jakob; Kottaridis, Panagiotis D; Yakoub-Agha, Ibrahim; Porras, Rocio Parody; Wagner, Eva Maria; Esteve, Jordi; Lanza, Francesco; Nagler, Arnon; Mohty, Mohamad, Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT), «BONE MARROW TRANSPLANTATION», 2022, 57, pp. 1556 - 1563 [articolo]
Zappasodi, Patrizia; Cattaneo, Chiara; Ferretti, Virginia Valeria ; Mina, Roberto; Ferreri, Andrés José María; Merli, Francesco; Oberti, Margherita; Krampera, Mauro; Romano, Alessandra; Zerbi, Caterina; Ferrari, Jacqueline; Cavo, Michele; Salvini, Marco; Bertù, Lorenza; Fracchiolla, Nicola Stefano; Marchesi, Francesco; Massaia, Massimo; Marasco, Vincenzo; Cairoli, Roberto; Scattolin, Anna Maria; Vannucchi, Alessandro Maria; Gambacorti-Passerini, Carlo; Musto, Pellegrino; Gherlinzoni, Filippo; Cuneo, Antonio; Pinto, Antonello; Trentin, Livio; Bocchia, Monica; Galimberti, Sara; Coviello, Elisa; Tisi, Maria Chiara; Morotti, Alessandro; Falini, Brunangelo; Turrini, Mauro; Tafuri, Agostino; Billio, Atto; Gentile, Massimo; Lemoli, Roberto Massimo; Venditti, Adriano; Della Porta, Matteo Giovanni; Lanza, Francesco; Rigacci, Luigi; Tosi, Patrizia; Mohamed, Sara; Corso, Alessandro; Luppi, Mario; Giuliani, Nicola; Busca, Alessandro; Pagano, Livio; Bruno, Raffaele; Grossi, Paolo Antonio; Corradini, Paolo; Passamonti, Francesco; Arcaini, Luca, Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 846 - 856 [articolo]Open Access
Seghatchian, Jerard; Pereira, Paulo; Lanza, Francesco, Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron, «TRANSFUSION AND APHERESIS SCIENCE», 2022, 61, pp. 103499 - 103499 [articolo]
De Lima, MJG; Kebriaei, P; Lanza, F; Cho, C; Popradi, G; Hemmer, MT; Zhang, MJ; Zhang, F; Shah, R; Welch, V; Tikka, S; Vandendries, E; Stelljes, M; Marks, DI; Saber, W, Veno-Occlusive Disease Risk and Other Outcomes in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia Who Received Inotuzumab Ozogamicin and Proceeded to Hematopoietic Stem Cell Transplantation: A Registry-Based, Observational Study, «BLOOD», 2022, 140, pp. 6023 - 6025 [abstract]
MARKS, David; DE LIMA, Marcos; KEBRIAEI, Partow; LANZA, Francesco; CHO, Christina; GIRALT, Sergio; POPRADI, Gizelle; HEMMER, Michael; ZHANG, Xin; SHAH, Richa; WELCH, Verna; VANDENDRIES, Erik; STELLJES, Matthias; SABER, Wael, A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), «HEMATOLOGY, TRANSFUSION AND CELL THERAPY», 2021, 43, pp. S34 - S34 [abstract]
Francesco Lanza, Ambiente e malattie del sangue, in: Trattato Italiano di Medicina d'Ambiente, Roma, Aldo Ferrara, 2021, pp. 433 - 450 [capitolo di libro]
Lazzaro, Carlo; Castagna, Luca; Lanza, Francesco; Laszlo, Daniele; Milone, Giuseppe; Pierelli, Luca; Saccardi, Riccardo, Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis, «BONE MARROW TRANSPLANTATION», 2021, 56, pp. 1876 - 1887 [articolo]Open Access
Passamonti, Francesco; Romano, Alessandra; Salvini, Marco; Merli, Francesco; Porta, Matteo G Della; Bruna, Riccardo; Coviello, Elisa; Romano, Ilaria; Cairoli, Roberto; Lemoli, Roberto; Farina, Francesca; Venditti, Adriano; Busca, Alessandro; Ladetto, Marco; Massaia, Massimo; Pinto, Antonio; Arcaini, Luca; Tafuri, Agostino; Marchesi, Francesco; Fracchiolla, Nicola; Bocchia, Monica; Armiento, Daniele; Candoni, Anna; Krampera, Mauro; Luppi, Mario; Cardinali, Valeria; Galimberti, Sara; Cattaneo, Chiara; La Barbera, Elettra Ortu; Mina, Roberto; Lanza, Francesco; Visani, Giuseppe; Musto, Pellegrino; Petrucci, Luigi; Zaja, Francesco; Grossi, Paolo A; Bertù, Lorenza; Pagano, Livio; Corradini, Paolo, COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 195, pp. 371 - 377 [articolo]Open Access
